Orion Corp - Company Profile
Powered by 
All the data and insights you need on Orion Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Orion Corp Strategy Report
- Understand Orion Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Orion Corp (Orion) develops, manufactures and markets human and veterinary pharmaceuticals, and active pharmaceutical ingredients (APIs). Its products include pharmaceuticals for the treatment of central nervous system disorders, cancer and respiratory diseases. The company's pipeline encompasses investigational candidates for the treatment of amyotrophic lateral sclerosis, Parkinson’s disease, chronic obstructive pulmonary disease, and various cancer types. Orion’s client base consists of healthcare service providers and professionals, such as doctors, pharmacies, veterinarians, hospitals, healthcare centers, clinics and laboratories. The company sells its products in European markets through own sales network and in international markets through several partners and distributors. Orion is headquartered in Espoo, Finland.
Headquarters
Finland
Address
Orionintie 1a, Espoo, 02200
Website
www.orion.fi
Telephone
358 10 4261
No of Employees
3,574
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
ORNBV (HEL)
Revenue (2022)
$1.4B
28.8%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
80.3%
(2022 vs 2021)
Market Cap*
$5.5B
Net Profit Margin (2022)
XYZ
40.0%
(2022 vs 2021)
* As of and is in US$
Orion Corp premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Human Prescription Medicines: | - | - |
| CNS products: | Contract Manufacturing | Stalevo |
| Stalevo | Manufacturing and Packaging: | Comtess |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Regulatory Approval | In November, Orion Animal Health received approval for Bonqat from the U.S. Food and Drug Administration for the alleviation of acute anxiety and fear associated with transportation and veterinary visits in cats. |
| 2023 | Contracts/Agreements | In July, the company and Aiforia entered into a partnership to develop AI-based image analysis solutions for preclinical research and product development. |
| 2023 | Plans/Strategy | In June, the company announced its plans to invest a total of approximately EUR 30 million to increase its production capacity in Finland. |
Competitor Comparison
| Key Parameters | Orion Corp | F. Hoffmann-La Roche Ltd | Merck & Co Inc | Abbott Laboratories | GSK plc |
|---|---|---|---|---|---|
| Headquarters | Finland | Switzerland | United States of America | United States of America | United Kingdom |
| City | Espoo | Basel | Kenilworth | Abbott Park | Brentford |
| State/Province | - | - | New Jersey | Illinois | England |
| No. of Employees | 3,574 | 103,613 | 69,000 | 115,000 | 69,400 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Mikael Silvennoinen | Chairman | Executive Board | 2020 | 67 |
| Liisa Hurme | Chief Executive Officer; President | Senior Management | 2022 | 56 |
| Jari Karlson | Chief Financial Officer | Senior Management | 2002 | 62 |
| Hilpi Rautelin | Vice Chairman | Executive Board | 2012 | 62 |
| Satu Ahomaki | Senior Vice President - Generics and Consumer Health | Senior Management | 2023 | 57 |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward